MEDIUM confidence: 100% data completeness, but the composite (48) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 13.4%/yr (revenue basis).
Base free cash flow $11.3B (avg FY2023–FY2025; latest year $12.8B) · equity value $174.6B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$7.5M over 180 days (0 open-market buys, 68 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Avg target $215 (last qtr, 26 analysts) → $204 (last mo, 13) (-5.1%).
Buy-rated share 29% → 30% over ~3 months (+1pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $2.23 | $2.21 | -0.9% |
| Apr 2026 | $2.56 | $2.65 | +3.5% |
| Feb 2026 | $3.39 | $3.50 | +3.2% |
| Nov 2025 | $2.87 | $3.00 | +4.5% |
| Jul 2025 | $2.71 | $2.77 | +2.2% |
| Apr 2025 | $2.82 | $2.85 | +1.1% |
| Feb 2025 | $2.96 | $3.41 | +15.2% |
| Nov 2024 | $2.56 | $2.69 | +5.1% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $33.6B— | $44.2B+31.7% | $35.8B-19.0% | $39.0B+8.8% | $44.3B+13.7% |
| EPS (dil.) | $7.87— | $11.38+44.6% | $6.42-43.6% | $8.98+39.9% | $5.01-44.2% |
| Free Cash Flow | $8.6B— | $6.8B-21.0% | $9.8B+44.1% | $11.2B+13.3% | $12.8B+14.9% |
| Gross Margin | 57.5% | 57.8%+0.3pp | 55.7%-2.1pp | 56.2%+0.5pp | 55.4%-0.8pp |
| Operating Margin | 29.2% | 35.9%+6.7pp | 21.7%-14.1pp | 25.8%+4.1pp | 27.9%+2.1pp |
| Net Margin | 26.9% | 29.3%+2.3pp | 20.2%-9.1pp | 26.0%+5.8pp | 12.5%-13.5pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
The QScore of 48 for QCOM indicates a neutral outlook, driven by a mix of positive and negative factors. The stock scores high on value and profitability, with a reasonable P/E of 18.9 and strong ROE near 37%. However, growth and momentum categories weigh down the overall score, due to a significant decline in EPS growth and a recent 3-month return of -21.9%. The long-term and short-term scores are relatively close, with only a 4-point divergence.